Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
the actual benefit of CERVARIX remains substantial only the Marketing Authorisation indications recommended by the HCSP in the current vaccination schedule. |
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
WTVZmz2eKSQKMRkr
